Development of the new treatment strategy for cancer using the transgenic mice that induced the epithelial tumors
Project/Area Number |
19591927
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Obstetrics and gynecology
|
Research Institution | Kawasaki Medical School (2008-2009) University of Toyama (2007) |
Principal Investigator |
NAKAMURA Takafumi Kawasaki Medical School, 医学部, 教授 (20303969)
|
Co-Investigator(Kenkyū-buntansha) |
SAITO Shigeru 富山大学, 大学院・医学薬学研究部, (医学)教授 (30175351)
YAMAMOTO Hiroshi 富山大学, 生命科学先端研究センター, 准教授 (00108797)
|
Project Period (FY) |
2007 – 2009
|
Project Status |
Completed (Fiscal Year 2009)
|
Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2009: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2008: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2007: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | SV40T抗原 / トランスジェニックマウス / 水晶体腫瘍 / 自然免疫マクロファージ / NK細胞 / 漢方薬 / 自然免疫 / マクロファージ / 十全大補湯 / 補中益気湯 / 小柴胡湯 / p53 / pRB |
Research Abstract |
Herbal medicine (Juzentaihoto, Hochuekkito) extended duration of life of cancer bearing laboratory mouse significantly. These herbal medicine are able to activate natural immunity, and there would be a possibility that the immunology of cancer bearing laboratory mouse might be activated.
|
Report
(4 results)
Research Products
(9 results)